- Home
- MDLZ vs GSK Comparison
MDLZ vs GSK Comparison
Compare MDLZ & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDLZ
- GSK
- Stock Information
- Founded
- MDLZ 2000
- GSK 1715
- Country
- MDLZ United States
- GSK United Kingdom
- Employees
- MDLZ N/A
- GSK N/A
- Industry
- MDLZ Packaged Foods
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- MDLZ Consumer Staples
- GSK Health Care
- Exchange
- MDLZ Nasdaq
- GSK Nasdaq
- Market Cap
- MDLZ 88.5B
- GSK 71.7B
- IPO Year
- MDLZ N/A
- GSK N/A
- Fundamental
- Price
- MDLZ $65.59
- GSK $37.42
- Analyst Decision
- MDLZ Buy
- GSK Hold
- Analyst Count
- MDLZ 19
- GSK 4
- Target Price
- MDLZ $70.63
- GSK $47.00
- AVG Volume (30 Days)
- MDLZ 9.8M
- GSK 6.2M
- Earning Date
- MDLZ 04-29-2025
- GSK 04-30-2025
- Dividend Yield
- MDLZ 2.87%
- GSK 4.15%
- EPS Growth
- MDLZ N/A
- GSK N/A
- EPS
- MDLZ 3.42
- GSK 0.78
- Revenue
- MDLZ $36,441,000,000.00
- GSK $39,280,393,592.00
- Revenue This Year
- MDLZ $5.36
- GSK $7.60
- Revenue Next Year
- MDLZ $4.29
- GSK $5.24
- P/E Ratio
- MDLZ $19.18
- GSK $23.31
- Revenue Growth
- MDLZ 1.18
- GSK 3.46
- 52 Week Low
- MDLZ $53.95
- GSK $31.72
- 52 Week High
- MDLZ $76.06
- GSK $45.93
- Technical
- Relative Strength Index (RSI)
- MDLZ 47.14
- GSK 54.43
- Support Level
- MDLZ $66.13
- GSK $35.08
- Resistance Level
- MDLZ $69.09
- GSK $36.16
- Average True Range (ATR)
- MDLZ 1.84
- GSK 1.05
- MACD
- MDLZ -0.22
- GSK 0.28
- Stochastic Oscillator
- MDLZ 41.18
- GSK 97.58
About MDLZ Mondelez International Inc.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (49% of sales), chocolate (31%), gum/candy (11%), beverage (3%), and cheese and grocery (6%) aisles, as of the end of fiscal 2024. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one third of its revenue from developing markets, just more than one third from Europe, and the remainder from North America.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.